Top Markets
#1 ADO Protocol ADO Protocol +336.06%
#2 Islamic Coin Islamic Coin +155.41%
#3 GoPlus Security GoPlus Security +52.74%
#4 Starpower Starpower +34.19%
#5 GAIB AID GAIB AID +24.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.48%
#7 Nockchain Nockchain +14.59%
#8 Casper Network Casper Network +12.03%
#9 The Black Bull The Black Bull +11.77%
#10 o1.exchange o1.exchange +11.35%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Pozycja w akcjach #33275
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Cena akcji
$5.39
Kapitalizacja rynkowa
$7.87M
Zmiana (1 dzień)
-2.45%
Zmiana (1 rok)
5.80%
Kraj
US
Handel CNS Pharmaceuticals, Inc. (CNSP)

Kategoria

Healthcare
EPS dla CNS Pharmaceuticals, Inc. (CNSP)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy CNS Pharmaceuticals, Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla CNS Pharmaceuticals, Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE